Advisory Alpha, LLC Repligen Corp Transaction History

Advisory Alpha, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $21,767 - $30,365	-147 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$122.51 - $158.27 $18,008 - $23,265	147 New	147 $495,000
Q2 2020 Aug 14, 2020	SELL	$94.33 - $140.48 $10,187 - $15,171	-108 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$73.84 - $93.08 $20,675 - $26,062	-280 Reduced 72.16%	108 $10.7 Million
Q3 2019 Nov 13, 2019	BUY	$76.65 - $95.51 $29,740 - $37,057	388 New	388 $29,000
Q2 2019 Aug 16, 2019	SELL	$54.2 - $85.95 $5,420 - $8,595	-100 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$49.45 - $62.8 $4,945 - $6,280	100 New	100 $0

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Alpha, LLC with notifications on news.